Invacare Gross Profit 2010-2023 | IVCRQ

Invacare gross profit from 2010 to 2023. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
Invacare Annual Gross Profit
(Millions of US $)
2022 $175
2021 $239
2020 $245
2019 $262
2018 $268
2017 $269
2016 $284
2015 $313
2014 $347
2013 $367
2012 $427
2011 $474
2010 $472
2009 $493
Invacare Quarterly Gross Profit
(Millions of US $)
2023-03-31 $44
2022-12-31 $48
2022-09-30 $31
2022-06-30 $48
2022-03-31 $48
2021-12-31 $63
2021-09-30 $60
2021-06-30 $61
2021-03-31 $55
2020-12-31 $66
2020-09-30 $60
2020-06-30 $57
2020-03-31 $63
2019-12-31 $68
2019-09-30 $68
2019-06-30 $65
2019-03-31 $61
2018-12-31 $68
2018-09-30 $66
2018-06-30 $67
2018-03-31 $67
2017-12-31 $68
2017-09-30 $71
2017-06-30 $65
2017-03-31 $65
2016-12-31 $69
2016-09-30 $73
2016-06-30 $74
2016-03-31 $68
2015-12-31 $81
2015-09-30 $78
2015-06-30 $77
2015-03-31 $77
2014-12-31 $88
2014-09-30 $85
2014-06-30 $92
2014-03-31 $83
2013-12-31 $86
2013-09-30 $94
2013-06-30 $94
2013-03-31 $94
2012-12-31 $91
2012-09-30 $109
2012-06-30 $116
2012-03-31 $111
2011-12-31 $85
2011-09-30 $131
2011-06-30 $135
2011-03-31 $123
2010-12-31 $97
2010-09-30 $132
2010-06-30 $126
2010-03-31 $118
2009-12-31 $135
2009-09-30 $131
2009-06-30 $118
2009-03-31 $108
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.000B $0.742B
Invacare Corporation is a leading manufacturer and distributor in its markets for medical equipment used in non-acute care settings. At its core, the company designs, manufactures and distributes medical devices that help people to move, breathe, rest and perform essential hygiene. The company provides clinically complex medical device solutions for congenital (e.g., cerebral palsy, muscular dystrophy, spina bifida), acquired (e.g., stroke, spinal cord injury, traumatic brain injury, post-acute recovery, pressure ulcers) and degenerative (e.g., ALS, multiple sclerosis, chronic obstructive pulmonary disease (COPD), elderly, bariatric) ailments. The company's products are important parts of care for people with a wide range of challenges, from those who are active and involved in work or school each day and may need additional mobility or respiratory support, to those who are cared for in residential care settings, at home and in rehabilitation centers.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $75.918B 20.77
Becton Dickinson (BDX) United States $66.130B 16.56
Cardinal Health (CAH) United States $30.812B 16.50
Straumann Holding AG (SAUHY) Switzerland $22.515B 0.00
Labcorp (LH) United States $21.029B 17.26
Cooper (COO) United States $17.974B 24.34
West Pharmaceutical Services (WST) United States $15.984B 32.75
Align Technology (ALGN) United States $14.238B 27.05
Henry Schein (HSIC) United States $9.680B 18.44
Merit Medical Systems (MMSI) United States $6.033B 30.81
DENTSPLY SIRONA (XRAY) United States $3.787B 10.30
Patterson (PDCO) United States $2.744B 14.66
CONMED (CNMD) United States $1.915B 14.90
STAAR Surgical (STAA) United States $0.800B 0.00
Lifevantage (LFVN) United States $0.211B 23.38
Pro-Dex (PDEX) United States $0.108B 16.47